Jula Inrig insider trades: Travere Therapeutics (TVTX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jula reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX | ↓ Sell | 44,674 | $62.34 | $2.8M | Direct | Sep 17, 2026 (2d) |
| May 6, 2026 | TVTX | ↓ Sell | 22,485 | $45.15 | $1.0M | Direct | May 6, 2026 (0d) |
| Apr 15, 2026 | TVTX | ↓ Sell | 8,233 | $42.01 | $346K | Direct | Apr 15, 2026 (0d) |
| Feb 4, 2026 | TVTX | ↓ Sell | 1,779 | $32.21 | $57K | Direct | Feb 5, 2026 (1d) |
| Feb 3, 2026 | TVTX | ↓ Sell | 6,956 | $32.12 | $223K | Direct | Feb 3, 2026 (0d) |
| Jan 6, 2026 | TVTX | ↓ Sell | 2,476 | $39.74 | $98K | Direct | Jan 7, 2026 (1d) |
| Jul 1, 2025 | TVTX | ↓ Sell | 815 | $14.65 | $12K | Direct | Jul 2, 2025 (1d) |
| Feb 12, 2025 | TVTX | ↓ Sell | 2,568 | $23.53 | $60K | Direct | Feb 12, 2025 (0d) |
| Feb 4, 2025 | TVTX | ↓ Sell | 5,273 | $20.12 | $106K | Direct | Feb 4, 2025 (0d) |
| Jan 6, 2025 | TVTX | ↓ Sell | 2,506 | $19.04 | $48K | Direct | Jan 6, 2025 (0d) |
| Sep 10, 2024 | TVTX | ↓ Sell | 684 | $12.98 | $9K | Direct | Sep 10, 2024 (0d) |
| Sep 9, 2024 | TVTX | ↓ Sell | 2,191 | $11.52 | $25K | Direct | Sep 9, 2024 (0d) |
| Feb 1, 2024 | TVTX | ↓ Sell | 2,174 | $8.53 | $19K | Direct | Feb 2, 2024 (1d) |
| Jan 4, 2024 | TVTX | ↓ Sell | 2,509 | $9.43 | $24K | Direct | Jan 5, 2024 (1d) |
| Jan 5, 2023 | TVTX | ↓ Sell | 2,493 | $20.75 | $52K | Direct | Jan 6, 2023 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TVTX insiders
Open-market trades in the last 12 months
About Jula Inrig's insider trades
Jula Inrig is EVP, Head of R&D & CMO at Travere Therapeutics (TVTX). Since Jan 5, 2023, Jula has reported no open-market purchases and 15 sales worth $4.9M on SEC Form 4. In the last 12 months: 6 sales ($4.5M).
Their filings also include grants and awards (9 filings), option exercises (3 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TVTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.